Literature DB >> 11063626

Activation mechanisms of nucleoside phosphoramidate prodrugs.

C L Freel Meyers1, R F Borch.   

Abstract

A series of thymidine and tetrahydrofurfuryl phosphoramidates bearing haloethyl or piperidyl substituents was synthesized and used to investigate the activation mechanisms of nucleoside phosphoramidate prodrugs. Structure assignments for the tetrahydrofurfuryl reaction products were confirmed by comparison to authentic samples. Structural assignments for thymidine phosphoramidate reaction products were made by analogy to the tetrahydrofurfuryl products. Generation of the phosphoramidate anion leads to cyclization and subsequent nucleophilic attack at carbon and phosphorus of the resulting aziridinium ion intermediate to give the observed products. Nucleophilic attack by water at carbon and phosphorus occurs without selectivity, supporting a mechanism of action of haloethylamine nucleoside prodrugs involving intracellular release of the nucleotide. Activation of the benzotriazolyl piperidyl phosphoramidates is followed by P-N bond hydrolysis; this reaction is subject to specific acid catalysis and to nucleophilic catalysis by 1-hydroxybenzotriazole. These results suggest that the mechanism of action of the piperidyl nucleoside phosphoramidates involves the intracellular release of the active nucleotide following P-N bond cleavage, presumably by the action of an endogenous phosphoramidase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063626     DOI: 10.1021/jm000302b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Design and synthesis of phosphotyrosine peptidomimetic prodrugs.

Authors:  Hugo Garrido-Hernandez; Kyung D Moon; Robert L Geahlen; Richard F Borch
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

2.  Intracellular targets for a phosphotyrosine peptidomimetic include the mitotic kinesin, MCAK.

Authors:  Rong Huang; Hyunju Oh; Allison Arrendale; Victoria A Martin; Jacob Galan; Eric J Workman; Jane R Stout; Claire E Walczak; W Andy Tao; Richard F Borch; Robert L Geahlen
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

Review 3.  Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis.

Authors:  Abraham J Waldman; Tai L Ng; Peng Wang; Emily P Balskus
Journal:  Chem Rev       Date:  2017-04-04       Impact factor: 60.622

4.  Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation.

Authors:  Nicholas A Lentini; Benjamin J Foust; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  J Med Chem       Date:  2018-09-26       Impact factor: 7.446

Review 5.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

6.  Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.

Authors:  Weidong Wu; Jennifer Sigmond; Godefridus J Peters; Richard F Borch
Journal:  J Med Chem       Date:  2007-06-29       Impact factor: 7.446

7.  Identification of activating enzymes of a novel FBPase inhibitor prodrug, CS-917.

Authors:  Kazuishi Kubota; Shin-Ichi Inaba; Rika Nakano; Mihoko Watanabe; Hidetaka Sakurai; Yumiko Fukushima; Kimihisa Ichikawa; Tohru Takahashi; Takashi Izumi; Akira Shinagawa
Journal:  Pharmacol Res Perspect       Date:  2015-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.